May 9, 2013

As part of her ongoing Industry Insights column for eyeforpharma, NAI President, Rita E. Numerof, Ph.D., looks at the shortcomings of big data, suggesting that far from being an all-encompassing cure, it’s simply one of many solutions to pharma’s growth problems. Her article, In Search of the Silver Bullet: The Illusion of Big Data describes the potential pitfalls that come from not examining data holistically and failing to provide necessary context for payers, patients, and physicians.

See full article here, published May 2013 in eyeforpharma.  Her earlier column on the subject of big data, Big Data and the Convergence of R&D and the Commercial Organization, can be found here.